Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effect of cholinergic treatment depends on cholinergic integrity in early Alzheimer’s disease
Nils Richter, Nora Beckers, Oezguer A. Onur, et al.
Brain (2017) Vol. 141, Iss. 3, pp. 903-915
Open Access | Times Cited: 68

Showing 26-50 of 68 citing articles:

Alzheimer-typical temporo-parietal atrophy and hypoperfusion are associated with a more significant cholinergic impairment in amnestic neurodegenerative syndromes
Nils Richter, Laura Breidenbach, Maximilian H.T. Schmieschek, et al.
Journal of Alzheimer s Disease (2025)
Closed Access
Design, synthesis and evaluation of novel L-tryptophan derivatives as multifunctional agents with cholinesterase inhibition, anti-β-amyloid aggregation, anti-inflammatory, antioxidant and neuroprotection properties against Alzheimer's disease
Haiyang Yu, Yinfang Chen, Huizhen Li, et al.
Bioorganic Chemistry (2025) Vol. 161, pp. 108478-108478
Closed Access
Memory network and cognitive reserve are associated with preserved and stimulated cholinergic neurotransmission
Cecilia Boccalini, Daniela Perani, Valentina Garibotto
Handbook of clinical neurology (2025), pp. 137-153
Closed Access
Study on Urine Metabolic Profile of Aβ25–35-Induced Alzheimer's Disease Using UHPLC-Q-TOF-MS
Yuanyuan Liu, Mengying Wei, Kexin Yue, et al.
Neuroscience (2018) Vol. 394, pp. 30-43
Closed Access | Times Cited: 31
Connectomics and molecular imaging in neurodegeneration
Gérard N. Bischof, Michael Ewers, Nicolai Franzmeier, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2019) Vol. 46, Iss. 13, pp. 2819-2830
Open Access | Times Cited: 27
Alterations of Brain Networks in Alzheimer’s Disease and Mild Cognitive Impairment: A Resting State fMRI Study Based on a Population-specific Brain Template
Yuan Luo, Tongtong Sun, Chunchao Ma, et al.
Neuroscience (2020) Vol. 452, pp. 192-207
Closed Access | Times Cited: 27
Understanding How Physical Exercise Improves Alzheimer’s Disease: Cholinergic and Monoaminergic Systems
Boyi Zong, Fengzhi Yu, Xiaoyou Zhang, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 16
Altered heart rate variability during sleep in mild cognitive impairment
Shawn Dexiao Kong, Camilla M. Hoyos, Craig L. Phillips, et al.
SLEEP (2020) Vol. 44, Iss. 4
Open Access | Times Cited: 22
Spatial topography of the basal forebrain cholinergic projections: Organization and vulnerability to degeneration
Taylor W. Schmitz, László Záborszky
Handbook of clinical neurology (2021), pp. 159-173
Closed Access | Times Cited: 20
Graph-Based Fusion of Imaging, Genetic and Clinical Data for Degenerative Disease Diagnosis
Rui Guo, Xu Tian, Hanhe Lin, et al.
IEEE/ACM Transactions on Computational Biology and Bioinformatics (2023) Vol. 21, Iss. 1, pp. 57-68
Closed Access | Times Cited: 7
Basal forebrain metabolism in Alzheimer's disease continuum: relationship with education
Brandt Nicolas, Alessandra Dodich, Daniela Perani, et al.
Neurobiology of Aging (2019) Vol. 87, pp. 70-77
Open Access | Times Cited: 19
Alzheimer's disease treatment: The share of herbal medicines.
Masoud Soheili, Mohammad Karimian, Gholamali Hamidi, et al.
(2021) Vol. 24, Iss. 2, pp. 123-135
Closed Access | Times Cited: 15
Age and Anterior Basal Forebrain Volume Predict the Cholinergic Deficit in Patients with Mild Cognitive Impairment due to Alzheimer’s Disease
Nils Richter, Lara-Sophia David, Michel J. Grothe, et al.
Journal of Alzheimer s Disease (2022) Vol. 86, Iss. 1, pp. 425-440
Closed Access | Times Cited: 10
Action of the Purinergic and Cholinergic Anti-inflammatory Pathways on Oxidative Stress in Patients with Alzheimer’s Disease in the Context of the COVID-19 Pandemic
Júlia Leão Batista Simões, Leilane Dayane Sobierai, Inayá F. Leal, et al.
Neuroscience (2022) Vol. 512, pp. 110-132
Open Access | Times Cited: 9
A Low-Molecular-Weight BDNF Mimetic, Dipeptide GSB-214, Prevents Memory Impairment in Rat Models of Alzheimer’s Disease
P. Yu. Povarnina, А. А. Волкова, O. N. Vorontsova, et al.
Acta Naturae (2023) Vol. 14, Iss. 4, pp. 94-100
Open Access | Times Cited: 5
Cognitive ageing and Alzheimer’s disease: the cholinergic system redux
David L. Sultzer
Brain (2018) Vol. 141, Iss. 3, pp. 626-628
Open Access | Times Cited: 15
Spatial distributions of cholinergic impairment and neuronal hypometabolism differ in MCI due to AD
Nils Richter, Nils Nellessen, Julian Dronse, et al.
NeuroImage Clinical (2019) Vol. 24, pp. 101978-101978
Open Access | Times Cited: 14
Post-treatment with Posiphen Reduces Endoplasmic Reticulum Stress and Neurodegeneration in Stroke Brain
Seong‐Jin Yu, Kuo‐Jen Wu, Eun-Kyung Bae, et al.
iScience (2020) Vol. 23, Iss. 2, pp. 100866-100866
Open Access | Times Cited: 13
Sensitivity Dependence on the Crystal Forms of a Fluorescence Quencher for Silicon Quantum Dots and Its Use in Acetylcholinesterase Assay
Wei Song, Xiaoping Zhang, Bo Lin, et al.
Analytical Chemistry (2021) Vol. 93, Iss. 44, pp. 14900-14906
Closed Access | Times Cited: 11
Enzymatic reaction modulated DNA assembly on graphitic carbon nitride nanosheets for sensitive fluorescence detection of acetylcholinesterase activity and inhibition
Tingting Chen, Yingfeng Qin, Beibei Wang, et al.
Microchimica Acta (2023) Vol. 190, Iss. 7
Closed Access | Times Cited: 4
The unfinished journey with modafinil and discovery of a novel population of modafinil-immunoreactive neurons
Jian‐Sheng Lin, Bernard Roussel, Alexandre Gaspar, et al.
Sleep Medicine (2018) Vol. 49, pp. 40-52
Closed Access | Times Cited: 11
Entorhinal Tau Predicts Hippocampal Activation and Memory Deficits in Alzheimer’s Disease
Nils Richter, Gérard N. Bischof, Julian Dronse, et al.
Journal of Alzheimer s Disease (2020) Vol. 78, Iss. 4, pp. 1601-1614
Closed Access | Times Cited: 9
Effects of Rivastigmine on Brain Functional Networks in Patients With Alzheimer Disease Based on the Graph Theory
Jiangtao Zhang, Jianan Cheng, Hua Yang
Clinical Neuropharmacology (2020) Vol. 44, Iss. 1, pp. 9-16
Open Access | Times Cited: 9
Novel 1,2,4-oxadiazole derivatives as selective butyrylcholinesterase inhibitors: Design, synthesis and biological evaluation.
Maryam Nazari, Elham Rezaee, Roshanak Hariri, et al.
EXCLI journal (2021) Vol. 20, pp. 907-921
Closed Access | Times Cited: 8
Normalized Theta but Increased Gamma Activity after Acetylcholinesterase Inhibitor Treatment in Alzheimer’s Disease: Preliminary qEEG Study
Ezgi Fide, Deniz Yerlikaya, Didem Öz, et al.
Clinical EEG and Neuroscience (2022) Vol. 54, Iss. 3, pp. 305-315
Closed Access | Times Cited: 6

Scroll to top